| Sign In to gain access to subscriptions and/or personal tools. |
Antithrombogenic Poly(vinyl chloride) with Heparin- and/or Prostaglandin I2-Immobilized in HydrogelsDepartment of Applied Chemistry Faculty of Engineering, Kagoshima University 1-2140 Korimoto Kagoshima 890, Japan
Department of Applied Chemistry Faculty of Engineering, Kagoshima University 1-2140 Korimoto Kagoshima 890, Japan
Department of Applied Chemistry Faculty of Engineering, Kagoshima University 1-2140 Korimoto Kagoshima 890, Japan
Department of Applied Chemistry Faculty of Engineering, Kagoshima University 1-2140 Korimoto Kagoshima 890, Japan
Department of Applied Chemistry Faculty of Engineering, Kagoshima University 1-2140 Korimoto Kagoshima 890, Japan
The Third Department of Internal Medicine Faculty of Medicine, Kagoshima University Usuki-cho 1208 Kagoshima 890, Japan
The Third Department of Internal Medicine Faculty of Medicine, Kagoshima University Usuki-cho 1208 Kagoshima 890, Japan
Tsukuba Research Laboratory Nippon Oil & Fats Co., Ltd. 5-10 Tokodai Tsukuba 300-26, Japan Poly(vinyl chloride) (PVC) with heparin- and/or prostaglandin I2 (PGI2)- immobilized on crosslinked polyacrylamide hydrogels were prepared by the ad dition of the dry hydrogels to a PVC tetrahydrofuran solution. Immobilized heparin was found to be continuously released from the PVC matrix at 37 ° C in a physiological saline. Antithrombogenic activity of PVCs with heparin and/or PGI2 was evaluated by activated partial thromboplastin time (aPTT), whole blood clotting time, and inhibition of platelet aggregation. The heparin- immobilized PVC's exhibited excellent anticoagulant activity and the PGI2 immobilized PVC's completely inhibit platelet aggregation of human blood after sitting for 46 h in a physiological saline.
Journal of Bioactive and Compatible Polymers, Vol. 4, No. 1,
4-16 (1989) |
|||